<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.2" -->
<rss version="0.92">
<channel>
	<title>Viraload &#187; ArKal Medical Raised $17.5M For Continuous Glucose Monitoring</title>
	<link>http://www.viraload.com</link>
	<description>Technology &#38; Start Ups that are Viral and Infectuous</description>
	<lastBuildDate>Tue, 17 Aug 2010 05:55:43 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>ArKal Medical Raised $17.5M For Continuous Glucose Monitoring</title>
		<description><![CDATA[


  <a href="http://www.viraload.com/wp-content/uploads/2008/09/arkal.jpg" title="akalmedlogo"><img src="http://www.viraload.com/wp-content/uploads/2008/09/arkal.jpg" alt="akalmedlogo" /></a>




  

ArKal Medical, Inc. raised $17.5 million in a Series B financing round led by Thomas McNerney &#38; Partners. Existing investors, Delphi Ventures and MedVenture Associates were also significant investors in this round.

ArKal Medical is developing a novel continuous glucose&#8230;]]></description>
		<link>http://www.viraload.com/2008/09/17/arkal-medical-raised-175m-for-continuous-glucose-monitoring/</link>
			</item>
</channel>
</rss>
